MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6505-1313-1322$20.00
Mol Pharmacol 65:1313-1322, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heubach, J. F.
Right arrow Articles by Kaumann, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heubach, J. F.
Right arrow Articles by Kaumann, A. J.

Epinephrine Activates Both Gs and Gi Pathways, but Norepinephrine Activates Only the Gs Pathway through Human {beta}2-Adrenoceptors Overexpressed in Mouse Heart

Jürgen F. Heubach, Ursula Ravens, and Alberto J. Kaumann

Institute of Pharmacology and Toxicology, Medical Faculty Carl Gustav Carus, Dresden University of Technology, Dresden, Germany (J.F.H., U.R.); and Department of Physiology, University of Cambridge, Cambridge, United Kingdom (A.J.K.)

Isoproterenol increases and decreases contractile force at low and high concentrations, respectively, through {beta}2-adrenoceptors overexpressed in transgenic mouse heart (TG4), consistent with activation of both Gs and Gi proteins. Using TG4 hearts, we demonstrated that epinephrine behaves like isoproterenol, but norepinephrine does not. Epinephrine both increased (-log EC50M = 9.4) and decreased (-log EC50M = 6.5) left atrial force. Pertussis toxin (PTX) abolished the negative inotropic effects of epinephrine, consistent with mediation through Gi protein. Norepinephrine only increased contractile force (-log EC50M = 7.5). Norepinephrine (10-100 µM) prevented the positive inotropic effects but hardly affected the negative inotropic effects of epinephrine. Cardiodepressive epinephrine concentrations (1-10 µM) antagonized the positive inotropic effects of norepinephrine. In the free wall of TG4 right ventricle, norepinephrine and low epinephrine concentrations caused positive inotropic effects, and high epinephrine concentrations caused PTX-sensitive negative inotropic effects, as observed in the left atrium. Epinephrine (10 nM), a concentration causing maximum increase in contractile force, and norepinephrine (1 and 100 µM) increased cAMP-dependent protein kinase activity in TG4 left ventricle. Cardiodepressive concentrations of epinephrine (1 and 100 µM) did not increase cAMP-dependent protein kinase activity. The inotropic results were simulated with a model of two {beta}2-adrenoceptor sites. For one site involved in receptor coupling to Gs, both epinephrine and norepinephrine compete. The other site, recognized by epinephrine but not by norepinephrine, leads to receptor Gi coupling.


Received August 13, 2003; accepted February 9, 2004

Address correspondence to: Dr. Alberto J. Kaumann, Department of Physiology, University of Cambridge, Downing Street, Cambridge CB2 3EG, United Kingdom. E-mail: ajk41{at}hermes.cam.ac.uk




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Wang, V. De Arcangelis, X. Gao, B. Ramani, Y.-s. Jung, and Y. Xiang
Norepinephrine- and Epinephrine-induced Distinct 2-Adrenoceptor Signaling Is Dictated by GRK2 Phosphorylation in Cardiomyocytes
J. Biol. Chem., January 25, 2008; 283(4): 1799 - 1807.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. Alessandri-Haber, O. A. Dina, E. K. Joseph, D. Reichling, and J. D. Levine
A transient receptor potential vanilloid 4-dependent mechanism of hyperalgesia is engaged by concerted action of inflammatory mediators.
J. Neurosci., April 5, 2006; 26(14): 3864 - 3874.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics